Healio9d
Adding anifrolumab superior to standard therapy alone, maintains remission in lupus
Patients on anifrolumab spent more time in remission and low disease activity, and reached those states more quickly, vs. placebo. Achieving these states can stave off permanent organ damage.
HealthDay on MSN1mon
Anifrolumab Tied to Less Organ Damage for Patients With Lupus
The anifrolumab arm included patients who initiated 300 mg anifrolumab in the Treatment of Uncontrolled Lupus via the ...
pharmaphorum9d
AZ fleshes out positive trial of revitalised lupus drug anifrolumab
After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...
pharmaphorum3y
FDA approves AZ's anifrolumab, ending 10-year lupus drug drought
Anifrolumab was all-but written off in 2018 after failing the phase 3 TULIP-1 trial, but bounced back with positive data from a second study – TULIP-2 – that has proved sufficient for the FDA ...